Haemonetics Corporation (HAE)

Haemonetics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Haemonetics stock has a consensus rating of "Buy" and an average price target of $80.2. The average 1-year stock price forecast is 22.46% higher than the current stock price, while the lowest is $62 (-5.33%) and the highest is $104 (+58.80%).

Price Target: $80.2 (+22.46%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$62	$80.2	$78	$104
Change	-5.33%	+22.46%	+19.10%	+58.80%

Analyst Ratings

The average analyst rating for Haemonetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	1	1	1	2
Buy	5	5	5	5	5	4
Hold	3	3	3	3	3	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Craig Bijou B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $72 → $80	Hold → Strong Buy	Upgrades	$72 → $80	+22.16%	May 22, 2026
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $94 → $89	Buy	Maintains	$94 → $89	+35.90%	May 12, 2026
Allen Gong JP Morgan	JP Morgan	Hold Maintains $74 → $62	Hold	Maintains	$74 → $62	-5.33%	May 8, 2026
Anthony Petrone Mizuho	Mizuho	Buy Maintains $80 → $70	Buy	Maintains	$80 → $70	+6.89%	Apr 13, 2026
Joanne Wuensch Citigroup	Citigroup	Hold Maintains $75 → $70	Hold	Maintains	$75 → $70	+6.89%	Mar 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.41B

Increased by 5.92%

from 1.33B

Revenue Next Year

1.49B

Increased by 5.31%

from 1.41B

EPS This Year

5.27

Increased by 157.21%

from 2.05

EPS Next Year

5.82

Increased by 10.47%

from 5.27

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Apr 2, 2022	Apr 1, 2023	Mar 30, 2024	Mar 29, 2025	Mar 28, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	993.20M	1.17B	1.31B	1.36B	1.33B	1.41B	1.49B
Revenue Growth	14.10%	17.67%	12.01%	3.96%	-1.97%	5.92%	5.31%
EPS	0.84	2.24	2.29	3.31	2.05	5.27	5.82
EPS Growth	-45.81%	166.67%	2.23%	44.54%	-38.07%	157.21%	10.47%
Forward PE	-	-	-	-	-	12.42	11.24
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2027	2028	2029	2030
High	1.5B	1.6B
Avg	1.4B	1.5B
Low	1.4B	1.4B

Revenue Growth

Revenue Growth	2027	2028	2029	2030
High	10.8%	11.4%
Avg	5.9%	5.3%
Low	1.7%	0.1%

EPS Forecast

EPS	2027	2028	2029	2030
High	5.52	6.41
Avg	5.27	5.82
Low	5.07	5.40

EPS Growth

EPS Growth	2027	2028	2029	2030
High	169.4%	21.6%
Avg	157.2%	10.5%
Low	147.2%	2.4%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.